The British Journal of Psychiatry (2008) 192: 306-307. doi: 10.1192/bjp.bp.107.046649
© 2008 The Royal College of Psychiatrists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Morgan, C. J. A.
Right arrow Articles by Curran, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgan, C. J. A.
Right arrow Articles by Curran, H. V.

SHORT REPORTS

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

Celia J. A. Morgan, PhD and H. Valerie Curran, PhD, DClinPsy

Clinical Psychopharmacology Unit, University College London, UK

Correspondence: Celia Morgan, Clinical Psychopharmacology Unit, Sub-Department of Clinical Health Psychology, University College London, Gower Street, London WC1E 6BT, UK. Email: c.morgan{at}ucl.ac.uk

Declaration of interest

None.

Cannabis contains various cannabinoids, two of which have almost opposing actions: {Delta}9-tetrahydrocannabinol ({Delta}9-THC) is psychotomimetic, whereas cannabidiol (CBD) has antipsychotic effects. Hair samples were analysed to examine levels of {Delta}9-THC and CBD in 140 individuals. Three clear groups emerged: `THC only', `THC+CBD' and those with no cannabinoid in hair. The THC only group showed higher levels of positive schizophrenia-like symptoms compared with the no cannabinoid and THC+CBD groups, and higher levels of delusions compared with the no cannabinoid group. This provides evidence of the divergent properties of cannabinoids and has important implications for research into the link between cannabis use and psychosis.


Related articles in BJP:

From the Editor's desk
Peter Tyrer
BJP 2008 192: 320. [Full Text]  



This article has been cited by other articles:


Home page
 Schizophr BullHome page
M. Yucel, E. Bora, D. I. Lubman, N. Solowij, W. J. Brewer, S. M. Cotton, P. Conus, M. J. Takagi, A. Fornito, S. J. Wood, et al.
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
Schizophr Bull, July 25, 2010; (2010) sbq079v1.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
C. Henquet, J. van Os, R. Kuepper, P. Delespaul, M. Smits, J. a. Campo, and I. Myin-Germeys
Psychosis reactivity to cannabis use in daily life: an experience sampling study
The British Journal of Psychiatry, June 1, 2010; 196(6): 447 - 453.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
M. Di Forti, C. Morgan, P. Dazzan, C. Pariante, V. Mondelli, T. R. Marques, R. Handley, S. Luzi, M. Russo, A. Paparelli, et al.
High-potency cannabis and the risk of psychosis
The British Journal of Psychiatry, December 1, 2009; 195(6): 488 - 491.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
D. Koethe, A. Giuffrida, D. Schreiber, M. Hellmich, F. Schultze-Lutter, S. Ruhrmann, J. Klosterkotter, D. Piomelli, and F. M. Leweke
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
The British Journal of Psychiatry, April 1, 2009; 194(4): 371 - 372.
[Abstract] [Full Text] [PDF]

eLetters:

Read all eLetters

"Cannabidiol and psychotic symptoms"
Satish K Karunakaran
BJP Online, 15 Apr 2008 [Full text]
Cannabis induced psychosis
Dr. Dev Vrat Singh
BJP Online, 1 Jul 2009 [Full text]